Feltquate David 4
4 · iTeos Therapeutics, Inc. · Filed Aug 5, 2024
Insider Transaction Report
Form 4
Feltquate David
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-08-01+350,000→ 350,000 totalExercise: $17.46From: 2025-08-01Exp: 2034-08-01→ Common Stock (350,000 underlying)
Footnotes (1)
- [F1]This stock option will vest over 4 years, with 25% of the stock option vesting on August 1, 2025, and thereafter in equal monthly installments over the next 36 months, subject to the Reporting Person's continued service through the applicable vesting date.